AIM
CO

Acrospire Investment Management’s Global Cord Blood Corporation CO Stock Holding History

Acrospire Investment Management’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,835
Closed -$27K – 1993
2017
Q2 		$27K Sell
2,835
-4,300
-60% -$34.3K 0.03% 1360
2017
Q1 		$48K Sell
7,135
-12,628
-64% -$74.8K 0.04% 1004
2016
Q4 		$121K Buy
+19,763
New +$98.4K 0.05% 777

Other funds holding CO

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
PM
Parametrica Management Wanchai, Hong Kong $88M AUM 48.84% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $1.24B AUM 2.91% 1-Year Est. Return

Acrospire Investment Management's CO Position: Q3 2017 in Review

Acrospire Investment Management sold out of Global Cord Blood Corporation (CO) in Q3 2017, closing a stake of 2,835 shares — an estimated $27K sold.

Acrospire Investment Management first reported a position in CO in Q4 2016 and held it in 3 quarters. The position peaked at $121K in Q4 2016. 52 funds tracked by Wall St. Rank hold CO as of Q3 2017.

  • Acrospire Investment Management reported no remaining Global Cord Blood Corporation position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 2,835 Global Cord Blood Corporation shares in Q3 2017, an estimated $27K.
  • Acrospire Investment Management first reported a position in Global Cord Blood Corporation in Q4 2016 and held it in 3 quarters.
  • Acrospire Investment Management's Global Cord Blood Corporation position peaked at $121K in Q4 2016.
  • 52 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.